Global Health Limited · NSE:MEDANTA

Global Health — Q3 FY2023 Earnings Presentation

45 slides from Global Health's earnings presentation, Feb 13, 2023

  1. Slide 1: Exchange filing cover letter

    13th February, 2023 Ref:- GHL/2022-23/EXCH/024 The General Manager The Manager Dept. of Corporate Services Listing Department BSE Limited, National Stock Exchange of India Limited P J Towers, Dalal Street, Exchange Plaza, C-1, Block G, Mumbai - 400 001 Bandra Kurla Complex, Bandra (E), Mumbai - 400

  2. Slide 2: Global Health Limited Investor Presentation Q3 FY 2023

    GLOBAL HEALTH LIMITED Dedicated to Life INVESTOR PRESENTATION 5 Q3 FY 2023 1

  3. Slide 3: Disclaimer

    Disclaimer This presentation, apart from historical information, contains some "forward-looking statements" including those describing the Company’s strategies, strategic direction, objectives, future prospects, estimates etc. These forward-looking statements involve a number of risks, uncertainties

  4. Slide 4: Contents

    Contents 01 Medanta’s Founding Principles, Journey and Purpose 02 The Medanta Model of Healthcare 03 Medanta Today 04 9M FY2023 Performance Update 05 Medanta: Poised to Deliver Sustainable Growth 3

  5. Slide 5: Medanta's Founding Principles, Journey and Purpose

    Medanta’s Founding Principles, 01 Journey and Purpose 4

  6. Slide 6: Medanta was founded to bring a new type of healthcare to India

    Medanta was founded to bring a new type of healthcare to India… … the human side of healthcare Healthcare is never only about science. It is also about the art of medicine – the human connection, putting the patient first, collaboration, the personal acts of empathy and the values that guide our dec

  7. Slide 7: Growth from a single flagship hospital in Gurgaon

    Growth from a single flagship hospital in Gurgaon… …to a network of 5 high quality hospitals across north India 2025E MEDANTA HOSPITAL 2021 NOIDA JAI PRABHA Plan for 550 beds 2019 MEDANTA SPECIALTY Expected to MEDANTA HOSPITAL begin phase I 2015 HOSPITAL PATNA operations with MEDANTA ABDUR LUCKNOW ~

  8. Slide 8: One of the largest private hospital chains in North and East India

    One of the largest private hospital chains in North and East India Infrastructure and High quality Awards and technology clinical talent accreditations Built to deliver the Full time doctors; National and international most complex care team based care recognition Network of 5 multi- 1,440+ doctors*

  9. Slide 9: Global Health Limited successful listing on November 16, 2022

    Global Health Limited successful listing on November 16, 2022 18 DIIs, 16 FIIs participated in the anchor book • Largest hospital IPO in India • QIB portion was oversubscribed 28.64 times • Marquee institutional investors such as: Government of Singapore (GIC), Nomura, Polar Capital, UBS; Sovereign

  10. Slide 10: Our Mission and Values

    Our Mission and Values Embracing a new era and redefining our purpose Core Values Patient centric care: Foster a culture where every one of us is MISSION committed to care for patients and their caregivers Our mission is to deliver Leadership and quality: Commit to delivering excellence in world cla

  11. Slide 11: The Medanta Model of Healthcare

    02 The Medanta Model of Healthcare Delivering the highest quality of medicine with care and compassion 10

  12. Slide 12: The Medanta Model of Healthcare

    The Medanta Model of Healthcare Delivering the highest quality of medicine with care and compassion Exceptional clinical talent What it means for patients and caregivers? • Super specialized doctors provide the highest quality of care through a team based integrated approach Trust based compassionat

  13. Slide 13: Exceptional clinical talent delivering the highest end of care

    Exceptional clinical talent delivering the highest end of care World leading clinicians deliver multispecialty integrated care through a doctor led model 1 Clinical team includes recipients of Padma Bhushan, 5 Almost all doctors work full-time and exclusively at Padma Shri, and BC Roy awards, in add

  14. Slide 14: Infrastructure designed to create a safe and efficient environment

    Infrastructure designed to create a safe and efficient environment World class infrastructure that creates the best possible space for healing • High proportion of OTs and ICUs; given the orientation towards higher end, complex clinical work • High focus on infection control practices; dedicated Air

  15. Slide 15: High standard of care enabled by the latest sophisticated technology

    High standard of care enabled by the latest sophisticated technology Providing the latest tools to enable our doctors to deliver the greatest care Artis-Zeego Da Vinci Robotic Endovascular Biplane Cath Lab System Surgical Cath Lab Enables cardiologists and Enables surgeons to Used for highly surgeon

  16. Slide 16: Innovative digital solutions to enhance care access and quality

    Innovative digital solutions to enhance care access and quality 1 2 3 4 Doctors EMR app Patient App Remote monitoring AI/ Predictive analytics E-CLINIC APP Developed a patient app that: • Offers appointment scheduling mechanism and pre- TELEMEDICINE payment Allows us to reach patients in DOCBOX • Al

  17. Slide 17: Over the last decade Medanta has become a beacon of clinical brilliance

    Over the last decade Medanta has become a beacon of clinical brilliance Renowned as the first-movers and the last-stop in Indian healthcare Life saving Creativity- 3D printed Pediatric liver transplant for an Successful Intestinal transplant titanium spine infant in 2020 in 2013 CABG on oldest patie

  18. Slide 18: Recognised for its clinical excellence both in India and globally

    Medanta: Recognised for its clinical excellence both in India and globally Best Private Hospital in India three years in a row Amrit Ratna Samman by All India Critical Care Hospital News 18 on India’s 75th Ranking Survey 2022 by Independence Day Times Health Survey National and International Quality

  19. Slide 19: Medanta Today

    03 Medanta Today Leading tertiary and quaternary service provider in India 18

  20. Slide 20: From our flagship Medicity campus we have grown to over ~2,500 beds

    From our flagship Medicity campus in Gurgaon, we have grown to over ~2,500 beds across 5 cities Largest private hospital beds in operation under one roof in Delhi (NCR), Uttar Pradesh and Bihar GURGAON LUCKNOW PATNA 1,391 beds; 271 ICU beds 475 beds; 130 ICU beds (950 planned) 330 beds; 57 ICU beds

  21. Slide 21: Diversified group of hospitals across 5 States

    Diversified group of hospitals across 5 States Over 400 million people live in the States with Medanta facilities Noida; Upcoming Hospital in Uttar Pradesh with estimated bed Diversification | Gurgaon vs. other units Gurgaon; Largest capacity of 550 to cater to single location Delhi/NCR and Western

  22. Slide 22: Experienced senior management team across units

    Experienced senior management team across units Clinical department heads chair operating and governance committees in each unit Dr. Naresh Trehan Pankaj Sahni Chairman and Group CEO & Director Managing Director Sanjeev Kumar Sumanta Ray Bhuvander Kaul Dr Sandeep Group CFO Chief Marketing Chief Proc

  23. Slide 23: Eminent Board of Directors

    Eminent Board of Directors Marquee domestic and foreign institutions as major shareholders Others Board of Directors 13.57% Promoter FII 33.08% Shareholding 9.30% pattern as on Mutual Funds Dr. Naresh Trehan 9.84% Chairman and Managing Director 31st December, 2022 Sunil Sachdeva 12.64% RJ Corp Limit

  24. Slide 24: 9M FY2023 Performance Update

    04 9M FY2023 Performance Update Continue to deliver strong financial performance 23

  25. Slide 25: 9M FY2023 performance summary

    9M FY2023 performance summary Consistently delivering strong growth with improved profitability INR 20,273 million INR 4,856 million INR 2,250 million Total Income EBITDA and Margins % Margins % Margin – 24% Margin – 11.1% PAT and 9M FY22 9M FY22 9M FY22 16,727 million 21.2% 3,976 million Margin – 2

  26. Slide 26: 9M FY2023 performance summary

    9M FY2023 performance summary Consistently delivering strong growth with improved profitability Consolidated Total Income of INR 20,273 million, grew by 21.2% y-o-y. The growth was driven by combination of factors such as higher inpatient volumes, increase in bed occupied days, and change in special

  27. Slide 27: Significant clinical accomplishments in 9 months

    Significant clinical accomplishments in 9 months Continuing the legacy of clinical excellence The Medanta Liver Transplant Team successfully performed the country’s first three-way liver transplant swap, or paired exchange, in which three patients suffering from terminal liver disease simultaneously

  28. Slide 28: Key operating metrics: Revenue and profitability

    Key operating metrics: Revenue and profitability Robust growth across all major metrics Total Income (INR million) EBITDA (INR million and margin %) +21.2% +22.1% 20,273 4,856 16,727 3,976 +19.0% +17.9% 6,946 7,062 1,458 1,721 1,719 5,934 Q3 FY22 Q2 FY23 Q3 FY23 9M FY22 9M FY23 Q3 FY22 Q2 FY23 Q3 FY

  29. Slide 29: Key operating metrics: Volumes, occupancies, ALOS

    Key operating metrics: Volumes, occupancies, ALOS Strong volume growth, increased bed capacity and improvements in ALOS Census and occupied beds ALOS (days) 2,080 2,111 2,019 1,830 1,748 3.86 3.53 3.26 3.24 3.24 1,224 1,247 1,194 1,100 1,079 Q3 FY22 Q2 FY23 Q3 FY23 9M FY22 9M FY23 Q3 FY22 Q2 FY23 Q3

  30. Slide 30: Key operating metrics: ARPOB and revenue mix

    Key operating metrics: ARPOB and revenue mix ARPOB growth driven by speciality mix and channel mix improvements ARPOB* (INR) IPD Revenue mix by payor category +4.3% +8.5% 55,954 58,203 58,367 58,494 53,926 60% 63% 64% 60% 63% 24% 24% 3% 23% 3% 26% 24% 4% 4% 3% 10% 2% 8% 2% 8% 2% 9% 2% 9% 2% Q3 FY22

  31. Slide 31: Diverse revenue mix across all complex specialties

    Diverse revenue1 mix across all complex specialties Shift away from Internal Medicine as Covid recedes Revenue mix by specialty 9M FY22 Revenue mix by specialty 9M FY23 20% 18% 21% 23% 4% 4% 10% 5% 19,201 15,987 INR million 4% INR million 12% 7% 3 12% 11% 7% 3 12% 7% 11% 11% 3 Heart Digestive Cancer

  32. Slide 32: Growth seen in both mature and new hospitals

    Growth seen in both mature and new hospitals New hospitals continue to show strong success in a very short timeframe Matured hospitals - Over 6 years Developing hospitals - Less than 6 years Total Income (INR million) EBITDA (INR million and margin %) Total Income (INR million) EBITDA (INR million a

  33. Slide 33: Profit and Loss Statement

    Profit and Loss Statement Nine Months Quarter INR million 9M FY22 9M FY23 Y-o-Y Growth % Q3 FY22 Q2 FY23 Q3 FY23 Y-o-Y Growth % Revenue from operations 16,462 19,908 20.9% 5,832 6,791 6,943 19.1% Other income 265 365 38.0% 102 155 119 16.4% Total income 16,727 20,273 21.2% 5,934 6,946 7,062 19.0% Co

  34. Slide 34: Operational Parameters

    Operational Parameters Nine Months Quarter Key metrics 9M FY22 9M FY23 Y-o-Y Growth % Q3 FY22 Q2 FY23 Q3 FY23 Y-o-Y Growth % Total Beds 2,404 2,571 6.9% 2,404 2,569 2,571 6.9% Census Beds 1,748 2,019 15.5% 1,830 2,080 2,111 15.4% Occupied Bed Days 296,454 328,253 10.7% 101,041 112,503 114,651 13.5%

  35. Slide 35: Medanta Poised to Deliver Sustainable Growth

    Medanta Poised to Deliver Sustainable Growth 05 Values based growth you can be proud of 34

  36. Slide 36: Medanta is well placed to deliver sustainable growth

    Medanta is well placed to deliver sustainable growth… …while maintaining its core values of patient centric care and clinical leadership and quality CONTINUITY OF CARE TECHNOLOGY Extend clinical THOUGHT ADVANCEMENT services outside LEADERSHIP Use technology to hospital and ENHANCE Build on our impro

  37. Slide 37: Ramp-up of developing hospitals to drive near term growth

    Ramp-up of developing hospitals to drive near term growth Well positioned to drive near term growth, benefitting from investments made till date Number of installed beds • Operational bed addition of 849 beds (i.e. 167 2,571 33% of the capacity) from FY19 to 228 102 65 December 2022 419 35 9 410 • S

  38. Slide 38: Medanta remains the preferred destination for clinical talent

    Medanta remains the preferred destination for clinical talent Significant additions in senior clinicians across all units New Specialty added in the unit Gurugram Lucknow Patna Dr. Randeep Guleria Dr. Gagan Gautam Dr. Neelam Vinay Dr. Harshvardhan Atreya Dr. Rajiv Ranjan Prasad Dr. Kishore Chairman-

  39. Slide 39: Women and Children Institute launched in Gurgaon and Lucknow

    Women and Children Institute launched in Gurgaon and Lucknow Obstetrics, neonatology and general and super speciality paediatrics now available in Medanta Medanta Gurugram launched Institute of Women and Children in February 2023 Medanta Lucknow launched Mother and Child care in April 2022 led by Dr

  40. Slide 40: On-going expansion projects on track for FY 2025

    On-going expansion projects on track for FY 2025 Additional bed additions will drive long term sustainable growth Planned growth in number of installed beds Noida construction on track 300-550 ~3,500-4,000 170-320 425-475 2,571 ~100 Existing Gurgaon Lucknow Patna Noida FY25E Dec 2022 • Planned bed a

  41. Slide 41: New asset light hospital partnership in Indore

    New asset light hospital partnership in Indore Capitalizing on existing brand and growing market in Indore Proposed hospital design About the project • Site identified in prominent location on MR 10 road • O&M project with partner building ‘warm shell’ • Total operational area of ~5 lakh sq. ft. • P

  42. Slide 42: Ensuring continuity of care by extending services outside hospitals

    Ensuring continuity of care by extending services outside hospitals Taking the care to the patient not just bringing the patient to the care Growth in OPD Pharmacy Medanta Labs Revenue (INR million)* • Started in January 2023 58% • Plan to expand presence 367% 625 in states with existing 536 hospita

  43. Slide 43: Aligning strategy with values to deliver positive results

    Aligning strategy with values to deliver positive results for all stakeholders Growth you can be proud of • Deliver the highest end of patient centric care by embracing the sickest patients and treating the most complex cases • Maintain our leadership and quality by strengthening our already excepti

  44. Slide 44: Annexure: Abbreviations and Definitions

    Annexure: Abbreviations and Definitions Abbreviations  INR : Indian Rupee  NABH : National Accreditation Board for Hospitals & Healthcare Providers  NABL : National Accreditation Board for Testing and Calibration Laboratories  JCI : Joint Commission International  OPD : Out-Patient Department 

  45. Slide 45: Contact us

    Contact us About Medanta Contact Details Founded by Dr. Naresh Trehan, a world-renowned cardiovascular and Ravi Gothwal – cardiothoracic surgeon who has been awarded the prestigious Padma Bhushan and the Padma Shri, the third- and fourth-highest Head of Investor Relations civilian awards in India, a

Global Health — Q3 FY2023 Earnings Presentation on 6ix